Latest Distributions News

Ronin Resources has confirmed early-stage gold, silver, and copper mineralisation at its La Punilla Project in Argentina, sparking plans for intensified exploration.

Veris Limited has reversed its FY24 loss to post a $2.0 million profit before tax in FY25, driven by digital growth and strategic acquisitions. The company’s focus on higher-margin consulting and advisory services underpins a positive outlook for FY26.

Latrobe Magnesium Limited has received a non-binding Letter of Interest from the U.S. Export Import Bank to finance up to A$200 million for its Stage 2 Commercial Magnesium Plant, aiming to strengthen critical mineral supply chains for the U.S.

Greenvale Energy has launched a new phase of exploration at its Oasis Uranium Project, leveraging advanced magnetic and satellite data to identify promising growth opportunities beyond known mineralisation.

Nexus Minerals reports outstanding gold assay results from its recent drilling at the Wallbrook Gold Project, confirming significant high-grade mineralisation near the Crusader-Templar deposit and launching a new aircore drilling program to explore further targets.

South32 reported a robust September quarter with a 12% rise in copper equivalent production and a 33% surge in manganese volumes, while advancing key projects and maintaining full-year guidance.

HUB24 has reported a record $5.2 billion in net inflows for Q1 FY26, boosting its Funds Under Administration to $146.5 billion and securing the top spot for adviser satisfaction in Australia.

Ramsay Health Care announces a fully franked ordinary distribution of AUD 2.9642 per security on its perpetual preference shares, reflecting a steady income stream for investors. The payment is scheduled for April 2026, subject to board and external approvals.

BCAL Diagnostics has launched a $10 million convertible note facility, with $5 million already committed, to strengthen its capital position and accelerate commercialisation of its cancer detection technologies.

Mesoblast Limited reports a 69% jump in net revenues from its pioneering cell therapy Ryoncil in Q1 FY2026, propelled by expanded physician adoption and new reimbursement pathways. The company also secures convertible note funding and plans pivotal adult trials.

Prospech Limited reports steady progress on rare earth element metallurgy at its Korsnäs project and promising gold-silver drill results in Slovakia, backed by a fully subscribed $2.1 million capital raising.

Wide Open Agriculture has developed a novel lupin protein milk formulation that overcomes longstanding technological hurdles, lodging a patent to protect its innovation and gearing up for global commercialisation.